21.15109/ARP/WG85Q0 Zoltán, Hegedűs Hegedűs Zoltán https://orcid.org/0000-0001-9459-1654 Biological Research Centre, Szeged ARP 2026 Medicine, Health and Life Sciences Zoltán, Hegedűs Hegedűs Zoltán Biological Research Centre, Szeged 2026-03-25 2026-03-25 21.15109/ARP/WG85Q0/CLZRV7 21.15109/ARP/WG85Q0/J4ARKJ 150727 60162 application/pdf application/pdf 1.0 Creative Commons Attribution-NonCommercial 4.0 International License. The rapid proliferation of high-throughput omics technologies has led to an unprecedented accumulation of publicly available biological datasets. While the technical possibilities of reanalyzing such data are widely recognized, the legal, ethical, and institutional frameworks governing their reuse remain complex and often underappreciated. This essay examines the legal and licensing landscape surrounding the reuse of omics data, with particular emphasis on differences between academic and industrial contexts and the specific sensitivities of medical research. Technical considerations are addressed in a supporting role, highlighting how legal constraints shape computational practice.